[Verapamil and nitrendipine in beta blocker-resistant hypertensive patients].
Edmonds
D
D
Förster
E
E
Wehling
M
M
Siegenthaler
W
W
Vetter
W
W
D001262:Atenolol / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009568:Nitrendipine; D014700:Verapamil / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D001262:Atenolol; D009568:Nitrendipine; D014700:Verapamil; D009543:Nifedipine
Verapamil und Nitrendipin bei betablockerresistenten Hypertonikern.